Psychedelic therapies are becoming mainstream. Deutsche Bank thinks this drug developer could triple
- Posted on March 29, 2026
- By CNBC
- 4 Views
Psychedelic therapies are becoming mainstream. Deutsche Bank thinks this drug developer could triple
This biopharma play with two key drugs for treatment-resistant depression could see its stock rise by more than 230%, according to a Deutsche Bank analyst.
